Wang Peng, Zheng Xiang-Long, Wang Yu-Huan, Tao Yun, Wang Wan-Chun
Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang, People's Republic of China.
Department of Interventional and Vascular Surgery, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.
Int J Gen Med. 2025 Apr 4;18:1945-1955. doi: 10.2147/IJGM.S513288. eCollection 2025.
This study aimed to examine the effects and the efficacy of a combination of interventional embolization and endocrine hormone therapy for Pelvic congestion syndrome (PCS).
We retrospectively analyzed 132 patients diagnosed with PCS, and divided them into three groups based on their therapeutic schedule. The visual analog scale (VAS), pelvic venous blood flow parameters, and serum hormone levels of the three groups were compared before and after treatment. Moreover, the clinical efficacy and long-term changes in ovarian reserve functions were analyzed. For the comparison of measurement data before and after treatment within the group, paired - sample - test was used for analysis. For the comparison between groups, one - way analysis of variance was applied. A P - value less than 0.05 indicated a statistically significant difference.
Patients in the study group had significantly lower pain degrees than in the control group I and the control group II at 24 h and the first month after the operation ( < 0.05). The degree of pain in patients in the study group was significantly lower than that in the control group I at the third and 6 months following the treatment ( < 0.05). The parameters of venous blood flow and ovarian reserve in patients treated with the combined endocrine hormone therapy were significantly better than those in patients not treated with endocrine hormone therapy ( < 0.05). The total effective rate of the study group was significantly higher than that of the control groups ( < 0.05).
A combination of precise interventional embolization and endocrine hormone therapy can rapidly and effectively relieve pain in patients with PCS. Compared with free coil embolization, this combination can effectively increase vascular tension, reduce congestion, inhibit ovarian function, reduce pelvic congestion, and relieve symptoms.
本研究旨在探讨介入栓塞与内分泌激素联合治疗盆腔淤血综合征(PCS)的效果及疗效。
回顾性分析132例诊断为PCS的患者,根据治疗方案将其分为三组。比较三组治疗前后的视觉模拟评分(VAS)、盆腔静脉血流参数和血清激素水平。此外,分析临床疗效及卵巢储备功能的长期变化。组内治疗前后计量资料比较采用配对样本t检验分析。组间比较采用单因素方差分析。P值小于0.05表示差异有统计学意义。
研究组患者术后24小时及术后第1个月疼痛程度明显低于对照组I和对照组II(P<0.05)。治疗后第3个月和第6个月,研究组患者疼痛程度明显低于对照组I(P<0.05)。联合内分泌激素治疗患者的静脉血流参数和卵巢储备明显优于未接受内分泌激素治疗的患者(P<0.05)。研究组总有效率明显高于对照组(P<0.05)。
精准介入栓塞与内分泌激素联合治疗可快速有效缓解PCS患者疼痛。与游离弹簧圈栓塞相比,该联合治疗可有效增加血管张力,减轻淤血,抑制卵巢功能,减少盆腔淤血,缓解症状。